Integral Diagnostics Limited (ASX:IDX)
Australia flag Australia · Delayed Price · Currency is AUD
2.180
-0.050 (-2.24%)
Aug 7, 2026, 4:10 PM AEST

Integral Diagnostics Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Integral Diagnostics stock has a consensus rating of "Strong Buy" and an average price target of $3.11. The average 1-year stock price forecast is 42.66% higher than the current stock price, while the lowest is $2.15 (-1.38%) and the highest is $3.80 (+74.31%).

Price Target: $3.11 (+42.66%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.15$3.11$3.20$3.80
Change-1.38%+42.66%+46.79%+74.31%

Analyst Ratings

The average analyst rating for Integral Diagnostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy998888
Buy333344
Hold000111
Sell000000
Strong Sell111000
Total131312121313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Buy
Maintains
$3.70
BuyMaintains$3.70+69.72%Jul 29, 2026
RBC Capital
RBC Capital
Buy
Maintains
$3.05$2.85
BuyMaintains$3.05$2.85+30.73%Jul 16, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$3.50
BuyMaintains$3.50+60.55%Jun 3, 2026
Bell Potter
Bell Potter
Buy
Maintains
$3.80
BuyMaintains$3.80+74.31%Jun 3, 2026
Goldman Sachs
Goldman Sachs
Hold
Upgrades
$2.15
HoldUpgrades$2.15-1.38%Jun 1, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
801.81M
from 627.22M
Increased by 27.84%
Revenue Next Year
851.60M
from 801.81M
Increased by 6.21%
EPS This Year
0.13
from 0.10
Increased by 25.67%
EPS Next Year
0.15
from 0.13
Increased by 16.25%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026
Revenue
350.70M360.93M440.76M469.70M627.22M801.81M
Revenue Growth
27.26%2.92%22.12%6.57%33.54%27.84%
Gross Profit
128.99M122.10M142.43M151.90M195.98M256.58M
Gross Margin
36.78%33.83%32.31%32.34%31.25%32.00%
Operating Income
49.37M38.62M38.47M42.17M57.93M95.80M
Net Income
31.27M14.60M25.04M-60.70M4.67M28.85M
EPS
----0.100.13
EPS Growth
----32.47%25.67%
Forward PE
24.9417.4225.9927.6720.3217.01
Dividend / Share
0.130.070.060.060.070.08
Dividend Growth
--44.00%-14.29%-3.33%12.07%24.65%
Free Cash Flow
48.41M16.84M20.14M37.44M57.44M48.67M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202620272028
High819.7M
Avg801.8M
Low784.0M

Revenue Growth

Revenue Growth202620272028
High
30.7%
Avg
27.8%
Low
25.0%

EPS Forecast

EPS202620272028
High0.13
Avg0.13
Low0.12

EPS Growth

EPS Growth202620272028
High
30.9%
Avg
25.7%
Low
13.7%